Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Number Of Exists:
N/A
Technology:
Neuromodulation
Funding Status:
IPO
Investment Stage:
N/A
Total Funding:
248400000
Last Funding Type:
Post-IPO Equity
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Investor Type:
N/A
Estimated Revenue:
$10M to $50M
Founded Date:
2003
Last Funding Date:
2021
Headquarters:
Malvern, Pennsylvania, United States
Employee Number:
101-250
Investors Number:
15